Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
Condition: Central Centrifugal Cicatricial Alopecia Interventions: Drug: Calcipotriol; Drug: Subject's already prescribed drug Sponsor: Wake Forest University Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2022 Category: Research Source Type: clinical trials
A Phase III Study in Subjects With Mild to Moderate Psoriasis.
Condition: Mild to Moderate Psoriasis Interventions: Drug: AKP02/AKVANO cutaneous spray (calcipotriol 50 μg/g + betamethasone 0.5 mg/g/ AKVANO); Drug: Enstilar Topical Product (calcipotriol 50 μg/g + betamethasone 0.5 mg/g); Other: Placebo Sponsor: Lipidor AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2022 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
Condition: Mild to Moderate Plaque Psoriasis Interventions: Drug: Calcipotriol/AKVANO, 50 μg/g cutaneous solution; Drug: Calcipotriol Ointment 50 micrograms/g; Other: Placebo Sponsors: Cadila Pharnmaceuticals; Lipidor AB, Svärdvägen 13 SE-182 33 Danderyd, Sweden Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2021 Category: Research Source Type: clinical trials
